Neonatal Heart Responds to Pressure Overload With Differential Alterations in Various Cardiomyocyte Maturation

Xiaoning Ding1, Shoubao Wang2, Ye Wang1

  • 1Shanghai Children's Medical Center, Pediatric Translational Medicine Institute and Shanghai Pediatric Congenital Heart Disease Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

Neonatal hearts adapt to pressure overload by increasing cardiomyocyte division and growth. This study reveals how the neonatal heart

Area of Science:

  • Cardiovascular Biology
  • Neonatal Physiology
  • Congenital Heart Disease Research

Background:

  • Right-sided congenital heart disease (CHD) often involves pressure overload from birth.
  • The neonatal heart's response to pressure overload is not well understood.
  • Previous work established a pulmonary artery banding (PAB) model in neonatal rats.

Purpose of the Study:

  • To investigate the neonatal heart's reaction to pressure overload.
  • To understand cardiomyocyte proliferation and maturation under stress.
  • To explore the molecular mechanisms driving cardiac adaptation.

Main Methods:

  • Utilized a pulmonary artery banding (PAB) model in neonatal rats.
  • Employed cardiomyocyte-specific lineage tracing.
  • Conducted transcriptomic analyses to assess gene expression profiles.

Main Results:

  • PAB accelerated the transition of mononuclear to multinucleated cardiomyocytes, promoting hypertrophy.
  • Elevated pressure overload increased cardiomyocyte mitotic activity and cytokinetic markers.
  • Transcriptomic data revealed a bivalent expression profile indicating concurrent hypertrophy and immature cardiomyocyte characteristics.

Conclusions:

  • Neonatal cardiomyocytes exhibit plasticity, adapting to pressure overload through hypertrophy and hyperplasia.
  • Pressure overload differentially impacts cardiomyocyte maturation programs.
  • The neonatal heart's response highlights potential therapeutic targets for CHD.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
272
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
173